Robert P. Sambursky,Robert W. Vandine,Peter Condon,Uma Mahesh Babu
申请号：
US15519217
公开号：
US20170239330A1
申请日:
2015.10.08
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Histatin formulations include at least two different histatins. Histatins are used before or after laser surgery. Histatins are also used to treat ocular viruses, fungi or parasites. Histatins may be used for corneal wound healing and as a treatment for ocular surface disease in humans and other animals. Histatin formulations for treating ocular wounds or ocular surface disease include a first peptide comprising a first histatin and a second peptide comprising a second histatin. A method of performing corneal laser surgery on at least one eye of a patient includes cutting a cornea of the eye of the patient with a surgical laser and administering a therapeutic amount of at least one medicament comprising at least one peptide to an ocular surface of the eye.
